Left ventricle recovery following TAVI

ORIGINAL RESEARCH

Apr 23
Left ventricle recovery following TAVI
Guy Witberg, Ran Kornowski et al.
This study assessed the likelihood of left ventricular recovery following transcatheter aortic valve implantation in patients with severe left ventricular dysfunction and severe aortic stenosis, and found that recovery was a major determinant of midterm mortality.

ORIGINAL RESEARCH

Apr 17
Immediate complete revascularisation in ACS and MVD
In patients with acute coronary syndrome and multivessel disease, immediate complete revascularization was non-inferior to staged revascularization in terms of the primary endpoint at 1 year, and was associated with a lower rate of myocardial infarction in those with three-vessel disease.
Immediate complete revascularisation in ACS and MVD
free

STATE-OF-THE-ART

Apr 15
Renal denervation in the management of hypertension

In State-of-the-Art, the authors summarise the rationale for RDN, review the available evidence, provide recommendations for a safe procedure, and discuss the role of RDN in current guidelines and clinical practice.

Renal denervation in the management of hypertension
free

EDITORIAL

Apr 23
The miracle of left ventricular recovery after transcatheter aortic valve implantation
Harold L. Dauerman, Rony Lahoud et al.
This study examined the outcomes of 914 patients with severely reduced left ventricular ejection fraction (≤30%) who underwent TAVI, finding that prior myocardial infarction, reduced kidney function, and low-flow, low-gradient aortic stenosis were associated with higher mortality.
free

EDITORIAL

Apr 23
Timing of revascularisation in acute coronary syndromes with multivessel disease – two sides of the same coin
Barbara E. Stähli, Julia Stehli et al.
This substudy of the BIOVASC trial suggests that immediate multivessel PCI is an effective and safe strategy for ACS patients with multivessel coronary artery disease, including complex three-vessel disease.
free

NEW ISSUE

Apr 15
The latest on renal denervation, left ventricular recovery after TAVI, achieving complete revascularisation in ACS and more

Everywhere we turn we are confronted by an ongoing debate about the dangers – and advantages – of artificial intelligence. In the last issue, we spoke about evidence, and here, one of our articles looks at artificial intelligence and the role it could play in one aspect of our clinical lives. There is no reason to believe that hard clinical data and artificial intelligence are necessarily opposed… but we still need to be vigilant. The jury is out, and the evidence needs to be collected – what do you think?

The latest on renal denervation, left ventricular recovery after TAVI, achieving complete revascularisation in ACS and more

ORIGINAL RESEARCH

Apr 9
Comparison of CAS- and CEA-related outcomes
Alberto Bramucci, Fausto Castriota et al.
This propensity-matched study found similar 30-day composite stroke, acute myocardial infarction, and death rates between carotid endarterectomy and carotid artery stenting in asymptomatic and symptomatic patients.
Comparison of CAS- and CEA-related outcomes
Receive our newsletter


FAITAVI trial design

TRIAL DESIGN

Apr 23
FAITAVI trial design
Flavio Ribichini, Giuseppe Tarantini et al.
FAITAVI is a randomized trial comparing angiography-guided versus physiology-guided coronary revascularization in patients with severe aortic valve stenosis and coronary artery disease undergoing TAVI.
Subscribe banner

ORIGINAL RESEARCH

Apr 1
Crushed prasugrel loading dose in STEMI patients
Jeroen M. Wilschut, Roberto Diletti, et al.
In STEMI patients with a prehospital large myocardial area at risk, administration of crushed prasugrel loading dose was associated with higher post-procedural TIMI 3 flow rates compared to integral prasugrel.
Crushed prasugrel loading dose in STEMI patients

ORIGINAL RESEARCH

Mar 29
Biological differences in paclitaxel- and sirolimus-coated balloons
Kazuki Aihara, Gaku Nakazawa, et al.
This preclinical study compared the drug effects and safety of low-dose paclitaxel, regular-dose paclitaxel and sirolimus-coated drug-coated balloons when inflated in rabbit iliac arteries. Paclitaxel-coated balloons showed higher efficacy and lower distal embolization risk than the sirolimus-coated balloon.
Biological differences in paclitaxel- and sirolimus-coated balloons

Mar 18
Meet Cory, your new AI Assistant!

Since the launch of its new website in February, EuroIntervention has harnessed the power of AI, integrating this cutting-edge technology in the development and improvement of features such as an optimised user interface and a powerful search engine.

Now, EuroIntervention is unveiling its new AI assistant – the first of its kind in the field of academic publishing - designed to accompany readers and enhance their reading experience.

Meet Cory, your new AI Assistant!

EDITORIAL

Mar 18
Comparative preclinical assessment of DCBs
Michael Joner; Léa Wild
A study compared three drug-coated balloon formulations in a porcine model, assessing drug transfer and tissue distribution as surrogates for clinical efficacy. Both paclitaxel formulations showed greater smooth muscle cell loss than the sirolimus formulation, but limitations were present.
Comparative preclinical assessment of DCBs
free

DEBATE

Mar 18
Ischaemic and viability testing for guiding PCI are overrated: pros and cons
Margaret B. McEntegart; Victoria Delgado et al.
Two large randomized trials found no benefit of an invasive strategy guided by ischaemia and viability testing over medical therapy alone for stable CAD patients, challenging the clinical usefulness of such testing.
Ischaemic and viability testing for guiding PCI are overrated: pros and cons
free

ORIGINAL RESEARCH

Mar 18
Bailout MANTA for transfemoral TAVI
This study evaluated the efficacy and safety of using the MANTA plug-based vascular closure device in 66 patients experiencing failed suture-based closure during transfemoral TAVI, finding it achieved haemostasis in 75.8% without complications in 86.4%.
Bailout MANTA for transfemoral TAVI

Trending articles
337.88

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
283.98

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved